Previous Issue
Volume 6, March
 
 

Nutraceuticals, Volume 6, Issue 2 (June 2026) – 11 articles

  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list.
  • You may sign up for e-mail alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.
Order results
Result details
Select all
Export citation of selected articles as:
15 pages, 472 KB  
Review
Ecdysterone: A Component of Dietary Supplements with Ergogenic Potential?
by Sareli Alonso León, Berta Pinto Robayna, Carlos Díaz Romero and Néstor Benítez Brito
Nutraceuticals 2026, 6(2), 31; https://doi.org/10.3390/nutraceuticals6020031 - 7 May 2026
Viewed by 293
Abstract
Ecdysterone is a natural compound proposed as an alternative to anabolic-androgenic steroids (AAS) due to its comparable ergogenic potential and more favorable safety profile. This narrative review summarizes current evidence using a standardized search protocol. Although many plants synthesize ecdysteroids, only a few [...] Read more.
Ecdysterone is a natural compound proposed as an alternative to anabolic-androgenic steroids (AAS) due to its comparable ergogenic potential and more favorable safety profile. This narrative review summarizes current evidence using a standardized search protocol. Although many plants synthesize ecdysteroids, only a few cultivated species—emphasizing quinoa and spinach—contribute meaningfully to dietary intake, while wild species such as those from the Ajuga genus contain substantially higher concentrations. Experimental studies indicate that ecdysterone enhances protein synthesis and physical performance through estrogen receptor-beta activation, avoiding the adverse effects typically associated with AAS. Additional pharmacological effects, including potential roles in breast cancer therapy and Alzheimer’s disease, have also been described. Ecdysteroids are generally considered non-toxic in humans; however, analysis of commercial supplements frequently reveals poor quality control and discrepancies between labeled and actual ecdysterone content. Although prevalence of use among athletes appears low, establishing urinary reference ranges to differentiate dietary exposure from supplement-derived intake is essential. Ecdysterone and its metabolites, 14-deoxy-ecdisterone and 14-deoxy-poststerone, are detectable in urine for more than two days depending on dosage. Given its ergogenic potential and detectability, ecdysterone may pose risks for unethical use and should be considered for inclusion in initial anti-doping testing procedures. Further research on ecdysteroids is required to elucidate their mechanisms of action, confirm the absence of adverse effects, and establish reference urinary concentration ranges that allow differentiation between diet-related metabolites and those derived from drug use. Full article
(This article belongs to the Special Issue Feature Review Papers in Nutraceuticals)
Show Figures

Graphical abstract

19 pages, 4073 KB  
Article
Four Weeks of CreaSol®Tyrosol Plus Creatine Supplementation Enhances Training Volume and Strength Endurance: A Randomized, Double-Blind, Placebo-Controlled Trial
by Eric M. Sikorski, Tony M. Zavala, Kenneth B. Hawkins II, Gabriel J. Wilson, Charlie Ottinger, Ryan Lowery and Jacob M. Wilson
Nutraceuticals 2026, 6(2), 30; https://doi.org/10.3390/nutraceuticals6020030 - 6 May 2026
Viewed by 204
Abstract
Tyrosol, a phenolic compound derived from olive products, exhibits anti-inflammatory, neuroprotective, and cardiometabolic properties, whereas creatine is a well-established ergogenic aid with documented benefits for muscular performance and emerging evidence for cognitive support. This 5-week randomized, double blind, placebo-controlled trial examined the effects [...] Read more.
Tyrosol, a phenolic compound derived from olive products, exhibits anti-inflammatory, neuroprotective, and cardiometabolic properties, whereas creatine is a well-established ergogenic aid with documented benefits for muscular performance and emerging evidence for cognitive support. This 5-week randomized, double blind, placebo-controlled trial examined the effects of Tyrosol, creatine, their combination, and placebo on resistance and aerobic exercise performance and psychomotor vigilance in healthy adults. Participants (n = 48; 18–50 years) consumed their assigned supplement for 4 weeks, after which changes in upper and lower body strength, submaximal resistance performance, aerobic capacity, lactate responses, plyometric performance, and acute cognitive function were assessed. The Tyrosol + Creatine condition produced the most consistent improvements in upper body resistance performance, particularly for higher load, higher volume bench press work. In contrast, neither the Tyrosol-alone group, the creatine-alone group, nor the placebo group achieved this effect, which suggests there is a synergistic effect between Tyrosol and creatine. No significant effects were observed for intermediate resistance loads, isometric lower body strength, grip strength, aerobic endurance, lactate responses, plyometric outcomes, or acute psychomotor vigilance. Collectively, these findings support the use of short-term co-supplementation with Tyrosol and low-dose creatine (without a loading phase) as a potentially beneficial strategy to enhance upper-body training quality in specific tests and improve upper-body strength endurance. Full article
Show Figures

Figure 1

18 pages, 1528 KB  
Review
Polyphenols and Cardiovascular Diseases: Molecular Insights and Nutraceutical Advances
by Ana Cecilia Cepeda-Nieto, Ileana Vera-Reyes, Gilberto Esquivel-Muñoz, Carlos Barrera-Ramírez, Raúl Rodríguez-Herrera, Jesús A. Padilla-Gámez, Eduardo Meneses-Sierra, Sunday Sedodo Nupo and Jesús Antonio Morlett-Chávez
Nutraceuticals 2026, 6(2), 29; https://doi.org/10.3390/nutraceuticals6020029 - 30 Apr 2026
Viewed by 338
Abstract
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide. Despite their often-asymptomatic progression and complex therapeutic management, a substantial proportion of CVDs is preventable through early intervention and lifestyle modification. However, effective pharmacological strategies to fully reduce disease burden and [...] Read more.
Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality worldwide. Despite their often-asymptomatic progression and complex therapeutic management, a substantial proportion of CVDs is preventable through early intervention and lifestyle modification. However, effective pharmacological strategies to fully reduce disease burden and associated risk factors remain limited. Polyphenols are a structurally diverse class of bioactive compounds widely distributed in plant-based foods, characterized by multiple phenolic and hydroxyl groups that confer potent redox-modulating properties. Increasing evidence indicates that dietary polyphenols exert cardioprotective effects through antioxidant, anti-inflammatory, and endothelial-modulating mechanisms. Experimental studies (in vitro and in vivo) have demonstrated that polyphenols regulate key molecular pathways involved in oxidative stress, inflammation, and vascular function, including PI3K/Akt/eNOS, AMPK/SIRT1, and Nrf2 signaling. In parallel, epidemiological and clinical evidence support their association with improvements in blood pressure, glycemic control, lipid profiles, and body weight, critical determinants of cardiovascular risk. Importantly, the biological response to polyphenol intake is highly variable and influenced by genetic background, metabolism, gut microbiota composition, and bioavailability constraints. This review provides an updated and integrative analysis of the molecular mechanisms underlying the cardioprotective effects of polyphenols, emphasizing their role in endothelial function and nitric oxide bioavailability. Additionally, it highlights recent advances in polyphenol-based nutraceuticals, discusses translational limitations, and outlines future perspectives for their application in cardiovascular disease prevention and management. Full article
(This article belongs to the Topic Functional Foods and Nutraceuticals in Health and Disease)
Show Figures

Graphical abstract

20 pages, 1759 KB  
Article
Study on the Prevalence of Oilseed Consumption in Morocco: Chemical Characteristics, Nutritional Profile, and Health Benefits of the Most Consumed Seeds
by Chayma Ait Naanaa, Ayoub Ainane, Sanaa Cherroud, Adnane El Yaacoubi and Tarik Ainane
Nutraceuticals 2026, 6(2), 28; https://doi.org/10.3390/nutraceuticals6020028 - 27 Apr 2026
Viewed by 246
Abstract
Oilseed consumption in Morocco has seen enhanced relevance due to its nutrient and functional value. This research paper was undertaken to establish the most consumed oilseeds in the country and to compare their chemical profiles, nutritional contents and health-promoting properties. Two-hundred and fifty [...] Read more.
Oilseed consumption in Morocco has seen enhanced relevance due to its nutrient and functional value. This research paper was undertaken to establish the most consumed oilseeds in the country and to compare their chemical profiles, nutritional contents and health-promoting properties. Two-hundred and fifty people spread out in various regions of Morocco were surveyed to obtain comprehensive information on the consumption patterns of the participants. The findings revealed that the percentage who consumed oilseeds was 91.2%, and the frequency of consumption was at a very low level, with the overall majority consuming the food less than once a week. Flax, sesame, sunflower, pumpkin, chia, anise, garden cress, black cumin, fennel, and fenugreek oilseeds were the most frequently consumed. At the same time, it is possible to note that the analysis of the available scientific evidence gave information about the chemical composition and the nutritional qualities of these oilseeds, which make their use of great advantage in the case of cardiovascular health, digestive system and skin health. Conclusively, although the consumption of oilseeds is still inconsistent, the research indicates that more of them can be consumed both nationally and internationally, especially with the help of nutritional education, awareness, and availability of fortified product campaigns. Full article
Show Figures

Graphical abstract

2 pages, 139 KB  
Correction
Correction: Di Simone et al. Unravelling the Neuroprotective Effects of a Novel Formulation Based on Plant Extracts, Mg, and Vitamin B6. Nutraceuticals 2025, 5, 5
by Simonetta Cristina Di Simone, Alessandra Acquaviva, Maria Loreta Libero, Nilofar Nilofar, Fatma Tunali, Paola Angelini, Giancarlo Angeles Flores, Gaia Cusumano, Lucia Recinella, Sheila Leone, Giustino Orlando, Gokhan Zengin, Luigi Menghini, Claudio Ferrante and Annalisa Chiavaroli
Nutraceuticals 2026, 6(2), 27; https://doi.org/10.3390/nutraceuticals6020027 - 24 Apr 2026
Viewed by 184
Abstract
References Update [...] Full article
2 pages, 463 KB  
Correction
Correction: Lastra et al. Silymarin as a Redox-Signalling and Proteostasis Modulator. Nutraceuticals 2026, 6, 25
by José Manuel Pérez de la Lastra, Celia María Curieses Andrés, Elena Bustamante Munguira, Celia Andrés Juan and Eduardo Pérez Lebeña
Nutraceuticals 2026, 6(2), 26; https://doi.org/10.3390/nutraceuticals6020026 - 22 Apr 2026
Viewed by 156
Abstract
In the original publication, there was a mistake in Figure 12 as published [...] Full article
Show Figures

Figure 12

43 pages, 5047 KB  
Review
Silymarin as a Redox-Signalling and Proteostasis Modulator
by José Manuel Pérez de la Lastra, Celia María Curieses Andrés, Elena Bustamante Munguira, Celia Andrés Juan and Eduardo Pérez Lebeña
Nutraceuticals 2026, 6(2), 25; https://doi.org/10.3390/nutraceuticals6020025 - 13 Apr 2026
Cited by 2 | Viewed by 519 | Correction
Abstract
Silymarin (Silybum marianum (L.) Gaertn. extract) is a widely used botanical for liver disease, yet clinical results remain inconsistent. Most mechanistic work uses supraphysiological aglycones, whereas humans are exposed predominantly to phase II conjugates that are strongly protein-bound and routed by transporters [...] Read more.
Silymarin (Silybum marianum (L.) Gaertn. extract) is a widely used botanical for liver disease, yet clinical results remain inconsistent. Most mechanistic work uses supraphysiological aglycones, whereas humans are exposed predominantly to phase II conjugates that are strongly protein-bound and routed by transporters toward bile and the intestinal mucosa. We reframe silymarin activity through a spatial pharmacology lens, proposing three post-intake windows: early (0–2 h) conjugate-dominant exposure with localised β-glucuronidase-mediated reactivation; intermediate (2–8 h) enterohepatic recirculation pulses; and late (8–48 h) microbial catabolite contributions. Each window engages distinct signalling modules—Keap1/NRF2, NF-κB, and AMPK-mTOR-TFEB—via transient redox events (quinone cycling, micro-H2O2 relays) and proteostatic remodelling (autophagy/mitophagy). We synthesise human pharmacokinetic and clinical evidence—with emphasis on MASLD and alcohol-associated liver disease—and show how formulation, meal timing, and microbiome metabotype determine which windows are engaged. Finally, we propose minimum reporting standards and falsifiable hypotheses to reduce between-study heterogeneity and enable precision use of silymarin. Full article
(This article belongs to the Special Issue Feature Review Papers in Nutraceuticals)
Show Figures

Graphical abstract

16 pages, 1006 KB  
Article
Pharmacokinetic Evaluation of Oleuropein from the Olive Tree (Olea europaea)
by Pradeep Subedi, Rocío Rivera Rodríguez, Pariksha Thapa, Daniel Lantvit and Jeremy James Johnson
Nutraceuticals 2026, 6(2), 24; https://doi.org/10.3390/nutraceuticals6020024 - 13 Apr 2026
Viewed by 372
Abstract
In this study, the pharmacokinetic (PK) characteristics of oleuropein present in the olive tree (Olea europaea) were determined. We developed and validated a highly sensitive ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) method to quantify oleuropein and its aglycone [...] Read more.
In this study, the pharmacokinetic (PK) characteristics of oleuropein present in the olive tree (Olea europaea) were determined. We developed and validated a highly sensitive ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) method to quantify oleuropein and its aglycone derivative, thereby establishing their pharmacokinetic properties in vitro and in vivo. Quantification of oleuropein and oleuropein aglycone was performed using selected reaction monitoring (SRM) with heated electrospray ionization in negative ion mode, employing mass transitions of m/z 275.06 and 307.137 for the respective analytes, and methylparaben as the internal standard. The calibration curve for both exhibited a range from 1 ng/mL to 1000 ng/mL, utilizing a total of 10 calibrator standards. The method demonstrated superior sensitivity, precision, and reproducibility, facilitating accurate quantification of analytes over a wide concentration range in biological matrices. To develop a pharmacokinetic profile, C57BL/6 male mice were administered oleuropein at a dose of 100 mg/kg body weight via oral gavage, and plasma levels were examined by LC-MS/MS. Oleuropein pharmacokinetics were evaluated exclusively, as plasma levels of oleuropein aglycone remained below the limit of quantification throughout the 24 h sampling period. Mass analysis of plasma samples identified multiple glucuronidated and sulfated metabolites, establishing Phase II metabolism as the dominant pathway governing the systemic disposition of oleuropein. In addition, the metabolic stability of the compounds was also investigated in mouse liver microsomes and S9 fractions to define the in vivo stability of oleuropein and oleuropein aglycone. Full article
Show Figures

Graphical abstract

12 pages, 1764 KB  
Article
Dietary Intervention with Hibiscus sabdariffa L. Beverage Residue Attenuates Dyslipidemia and Hepatic Steatosis in Late-Stage Type 2 Diabetic Rats
by Evelyn Regalado-Rentería, Jesús E. Serna-Tenorio, David G. García-Gutiérrez, Rosalía Reynoso-Camacho, Miriam A. Anaya-Loyola and Iza F. Pérez-Ramírez
Nutraceuticals 2026, 6(2), 23; https://doi.org/10.3390/nutraceuticals6020023 - 8 Apr 2026
Viewed by 363
Abstract
Roselle beverage residue (RBR), a by-product of Hibiscus sabdariffa L. processing, retains bioactive compounds, including soluble and insoluble dietary fiber and polyphenols. Its antihyperglycemic effect in type 2 diabetes mellitus (T2DM) has been previously demonstrated; however, its role in lipid metabolism remains unknown. [...] Read more.
Roselle beverage residue (RBR), a by-product of Hibiscus sabdariffa L. processing, retains bioactive compounds, including soluble and insoluble dietary fiber and polyphenols. Its antihyperglycemic effect in type 2 diabetes mellitus (T2DM) has been previously demonstrated; however, its role in lipid metabolism remains unknown. This study assessed the preventive and therapeutic potential of RBR on dyslipidemia and hepatic steatosis in a rodent model of late-stage T2DM characterized by hyperglycemia and hypoinsulinemia. Male Wistar rats with T2DM induced by a high-fat and high-fructose diet combined with streptozotocin received 6% RBR supplementation as either a preventive intervention (starting at week 1 in healthy rats or week 9 in insulin-resistant rats) or a therapeutic intervention (starting at week 14 in diabetic rats). After 17 weeks, RBR supplementation significantly reduced serum triglycerides and total cholesterol, attenuating hepatic lipid accumulation regardless of the timing of intervention. Hepatic Acadm expression, involved in fatty acid β-oxidation, was significantly upregulated in rats treated with RBR from week 1 and 9, whereas no significant modulation was observed for genes related to fatty acid synthesis or uptake. These findings suggest that RBR supplementation may contribute to improving lipid metabolism and hepatic steatosis in a rat model of late-stage T2DM. Full article
Show Figures

Graphical abstract

19 pages, 1981 KB  
Article
An Exploratory Study on a Multispecies Probiotic Formulation and Markers of Intestinal Health in Healthy People
by Maria Cristina Verdenelli, Maria Magdalena Coman, Francesco Martino Carpi and Stefania Silvi
Nutraceuticals 2026, 6(2), 22; https://doi.org/10.3390/nutraceuticals6020022 - 1 Apr 2026
Viewed by 572
Abstract
This study aimed to explore the efficacy of oral supplementation with 11 probiotic strains, combined in the strain mix Probatech™ (Centro Sperimentale del Latte S.r.l Strada Provinciale per Merlino, 326839 Zelo Buon Persico (LO), Italy) and delivered through the food supplement PROBAFLOR and [...] Read more.
This study aimed to explore the efficacy of oral supplementation with 11 probiotic strains, combined in the strain mix Probatech™ (Centro Sperimentale del Latte S.r.l Strada Provinciale per Merlino, 326839 Zelo Buon Persico (LO), Italy) and delivered through the food supplement PROBAFLOR and how it plays a positive role in maintaining normal intestinal function, providing benefits in healthy adult subjects. A 16-week, randomized, double-blind, placebo-controlled clinical study was conducted starting with 60 participants. Participants were randomly assigned to either the probiotic or placebo group. Participants were asked to provide one faecal sample at the beginning of the study, another one after 12 weeks of supplementation and the final one after 16 weeks. Amplicon 16S rRNA gene sequencing and GC-MS Short-Chain Fatty Acid (SCFA) profiling were performed on the faecal samples. Participants filled out questionnaires to assess their gastrointestinal health and psychological well-being. The overall mean GIQLI scores increased in both groups over time. The increases were significant within both groups but not between groups. Following the administration of PROBAFLOR, Shannon and Simpson diversity indices showed a significant increase at day 90 (week 12) (p < 0.05), demonstrating that the intervention effectively enhanced gut microbiota diversity. A shift in the intestinal microbiota towards SCFA-producing families and genera was observed. Moreover, the change in total and single SCFAs was significantly different between probiotic and placebo groups at the end of the supplementation period. Once-daily consumption of the PROBAFLOR probiotics formula regulated gut microbiota balance by modulating SCFA production. It may be beneficial for gut health, improving defecation habits and satisfaction, normalizing stool frequency, and promoting bacterial metabolism. Full article
Show Figures

Graphical abstract

20 pages, 4220 KB  
Article
Comparative Study of Anti-Inflammatory and Antimicrobial Potentials of Natural By-Products
by Na-Hyeon Park, Ji-A Byeon, Moon-Pil Jung, Ju-Young Kim, Seulki Yoon, Gyu Hoon Kim, Bo-Ae Kim and Yong-Jin Kwon
Nutraceuticals 2026, 6(2), 21; https://doi.org/10.3390/nutraceuticals6020021 - 30 Mar 2026
Viewed by 416
Abstract
Natural by-products (NBPs), including pomace, peels, stems, and skins, account for over 50% of materials generated during fresh fruit processing. Most of these are discarded or landfilled, contributing to environmental pollution. NBPs are rich in bioactive compounds, including polyphenols and flavonoids, suggesting their [...] Read more.
Natural by-products (NBPs), including pomace, peels, stems, and skins, account for over 50% of materials generated during fresh fruit processing. Most of these are discarded or landfilled, contributing to environmental pollution. NBPs are rich in bioactive compounds, including polyphenols and flavonoids, suggesting their potential as functional ingredients for health promotion. Accordingly, twelve types of NBPs from Korea were extracted with 70% ethanol. Each extract was comparatively evaluated at a uniform concentration for antioxidant, tyrosinase inhibition, and elastase inhibition activities. Anti-inflammatory and antimicrobial activities were additionally evaluated to identify extracts with superior overall activity profiles. Based on these findings, four extracts exhibiting the highest activities were combined, and the NBP complex was further tested for its antioxidant, anti-inflammatory, and antimicrobial effects. Although certain individual NBPs extracts showed strong activities, the NBP complex exhibited enhanced overall effects. These findings indicate that selected NBPs, both individually and in combination, possess significant potential as health-promoting functional ingredients. The study provides scientific evidence supporting the valorization of fruit processing residues into value-added products while addressing environmental concerns associated with their disposal. Full article
(This article belongs to the Topic Functional Foods and Nutraceuticals in Health and Disease)
Show Figures

Graphical abstract

Previous Issue
Back to TopTop